We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cosmetic Surgery Provides Significant Migraine Relief

By HospiMedica International staff writers
Posted on 13 Aug 2014
A new study shows that a non-endoscopic approach to migraine treatment could be useful for surgeons with little experience, as well as in patients with challenging anatomy.

Researchers at Louisiana State University (LSU; Baton Rouge, USA) and Harvard Medical School (Boston, MA, USA) conducted a study in 35 patients who suffered from chronic nerve compression migraine headaches, confirmed by previous positive response to Botox or nerve block treatments. More...
The patients underwent 43 trigger deactivation procedures via non-endoscopic plastic surgery techniques. Pre- and 12-month post-operative questionnaires and patient charts were reviewed, and response to surgery in terms of migraine symptom relief and adverse events were evaluated.

The procedure is based on the theory that migraine headaches arise due to inflammation of trigeminal nerve branches in the head and neck caused by irritation of the surrounding musculature, bony foramen, and perhaps fascia bands. Accordingly, surgical treatment of the migraines involves removing the relevant tissues, following clinical evaluation and diagnostic injections of botulinum toxin to locate the trigger sites. The specific surgical procedure varies according to the individual’s migraine trigger site.

The results showed an overall positive response rate of 90.7%. Migraine headaches were totally eliminated in 51.3% of the patients, with about a fifth of them experiencing an 80% reduction of symptoms; 28.2% had resolution between 50%–80%. No significant effect was reported following 9.3% of the procedures. There were no major adverse events reported. The study was published ahead of print on June 16, 2014, in Plastic and Reconstructive Surgery.

“Surgery is a valid treatment for migraines in certain patients. We believe that these patients should have ready access to migraine trigger site decompression surgery,” said study coauthor Assistant Professor of clinical surgery Oren Tessler, MD, of the LSU Health Sciences Center, and colleagues. “Although larger studies are needed, we have shown that we can restore these patients to full and productive lives.”

Migraine is a debilitating condition characterized by moderate to severe headaches, and is three times more common in women than in men. The typical migraine headache is unilateral pain and pulsating in nature, lasting from 4 to 72 hours; symptoms include nausea, vomiting, photophobia (increased sensitivity to light), phonophobia (increased sensitivity to sound), and is aggravated by routine activity. Approximately one-third of people who suffer from migraine headaches perceive an aura—unusual visual, olfactory, or other sensory experiences that are a sign that the migraine will soon occur.

Related Links:

Louisiana State University
Harvard Medical School



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.